IVF INVO Bioscience Projected Price to Earnings

Brandmark of INVO Fertility Corp (IVF)

INVO Fertility Inc (IVF) revenue is based on inertial interest in INVOcell systems, although a shortage of components from Asia is hindering scaling. Comparing the business's forward P/E multiple on GURU.Markets, we see that the 0.00 indicator determines the status of the valuation parameter. The company's current success relies on the accessibility of IVF procedures and government regulation in the field of reproductive health.

IVF - invobioscience.com Projected Price to Earnings Ratio over the range 04/29/2025 - 11/15/2026

Financial and market metric breakdowns for invobioscience.com (IVF)

Fundamental company analysis:invobioscience.com
Product sample of INVO Fertility Inc

The unique INVOcell technology provides INVO Fertility Inc (IVF) with sustainable demand in reproductive medicine, making the analysis of future earnings critical for business valuation. The company's forward P/E ratio compares the current share price with projected net income, allowing investors to determine the extent of the asset's premium and avoid a value trap when selecting an entry point.

Competitors of INVO Fertility Inc (IVF)

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings AORT (Artivion)|ENOV (Enovis Corp) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Inc. IART|ESTA - Projected Price to Earnings|Beta Bionics, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED CORPORATION|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen Surgical) - Forward P/E Multiple|SI-BONE Corp (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Forward P/E Multiple bioventus.com (BVS)|Forward P/E Multiple KIDS (OrthoPediatrics Corp)|Forward P/E Multiple Treace Medical Concepts Inc TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight, Inc.) - Projected Price to Earnings|ClearPoint Neuro Inc. - Future Price to Earnings Multiple|STXS (Stereotaxis Corporation) - Forward P/E Multiple|Projected Price to Earnings Ratio Neuronetics Inc. STIM|Future Price to Earnings Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Forward Price to Earnings Multiple|Anika Therapeutics Inc. - Projected Price to Earnings|Forward P/E Multiple InspireMD, Inc. NSPR|Jin Medical International Ltd. - Forward P/E Multiple|Market Cap to Projected Earnings Vivani Medical VANI|Xtant Medical (XTNT) - Future Price to Earnings|Price to Expected Earnings Ratio NMTC (NeuroOne Medical Technologies Corp.)|Future Price to Earnings modular-medical.com|Projected Price to Earnings Ratio myomo.com MYO|Forward P/E Multiple COCH|VVOS - Projected Price to Earnings Ratio|Future Price to Earnings enVVeno Medical NVNO|SINT: Price to Future Earnings Ratio|TNON: Projected Price to Earnings|rewalk.com - Market Cap to Future Earnings Ratio|AMIX: Forward P/E Multiple|BBLG (Bone Biologics Corp.) - Future Price to Earnings|Projected Price to Earnings AXNX|Biolase Inc. (BIOL) - Market Cap to Projected Earnings|Future Price to Earnings Dynatronics Corp. (DYNT)|Forward P/E Multiple Paragon 28 (FNA)|Future Price to Earnings INVO Bioscience INVO